We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
Turnover
22.5%
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
-6.12%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.96B
AUM Growth
-$641M
(-11%)
Cap. Flow
-$193M
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
23.33%
Holding
765
New
46
Increased
242
Reduced
270
Closed
98
Avg Time Held
1.5
years
Top 10 Avg Time Held
0.9
years
Top 20 Avg Time Held
0.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Manhattan Associates
MANH
|
+$33.6M |
| 2 |
Amazon
AMZN
|
+$32.3M |
| 3 |
CEB
CEB Inc.
CEB
|
+$27.7M |
| 4 |
Gilead Sciences
GILD
|
+$27.3M |
| 5 |
Merck
MRK
|
+$25.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$49.9M |
| 2 |
TWX
Time Warner Inc
TWX
|
+$30.5M |
| 3 |
Stericycle Inc
SRCL
|
+$29.3M |
| 4 |
Macquarie Infrastructure Holdings, LLC
MIC
|
+$25M |
| 5 |
Sunoco
SUN
|
+$21.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.16% |
| 2 | Financials | 16.84% |
| 3 | Consumer Discretionary | 14.26% |
| 4 | Technology | 13.32% |
| 5 | Industrials | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
501
Ares Capital
ARCC
$13.4B
| $166K | ﹤0.01% |
11,485
-180
| -2% | -$2.82K |
2014 Q1
6 quarters
|
|
502
Rithm Capital
RITM
$4.84B
| $159K | ﹤0.01% |
12,136
| – | – |
2015 Q1
2 quarters
|
|
503
Sociedad Química y Minera de Chile
SQM
$17.2B
| $154K | ﹤0.01% |
10,865
-1,525
| -12% | -$22K |
2014 Q1
6 quarters
|
|
504
Barrick Mining
B
$67.2B
| $127K | ﹤0.01% |
+19,991
| New | +$150K |
2015 Q3
0 quarters
|
|
505
Xerox
XRX
$324M
| $103K | ﹤0.01% |
+4,002
| New | +$111K |
2015 Q3
0 quarters
|
|
506
Wendy's
WEN
$1.28B
| $87K | ﹤0.01% |
10,000
| – | – |
2014 Q3
4 quarters
|
|
507
SiriusXM
SIRI
$9.09B
| $78K | ﹤0.01% |
2,079
-584
| -22% | -$22.4K |
2013 Q2
9 quarters
|
|
508
Ultra Clean Holdings
UCTT
$2.31B
| $78K | ﹤0.01% |
+13,601
| New | +$89.8K |
2015 Q3
0 quarters
|
|
|
ELI
509
DELISTED
ELITE PHARMACEUTICAL
ELI
| $67K | ﹤0.01% |
290,880
| – | – |
2013 Q2
9 quarters
|
|
|
FCFP
510
DELISTED
FIRST COMMUNITY FINANCIAL PARTNERS INC.
FCFP
| $65K | ﹤0.01% |
+10,000
| New | +$68.2K |
2015 Q3
0 quarters
|
|
|
SVLC
511
DELISTED
SILVERCREST MINES INC ORD SHS (CDA)
SVLC
| $62K | ﹤0.01% |
70,000
-16,000
| -19% | -$14.2K |
2013 Q2
9 quarters
|
|
|
PLM
512
DELISTED
PolyMet Mining Corp.
PLM
| $60K | ﹤0.01% |
8,880
+1,000
| +13% | +$9.21K |
2013 Q2
9 quarters
|
|
|
FTR
513
DELISTED
Frontier Communications Corp.
FTR
| $52K | ﹤0.01% |
735
-185
| -20% | -$14K |
2014 Q1
6 quarters
|
|
|
ECT
514
DELISTED
ECA Marcellus Trust 1 Interest
ECT
| $51K | ﹤0.01% |
30,000
| – | – |
2014 Q3
4 quarters
|
|
515
DELISTED
Meta Materials Inc. Common Stock
MMAT
| $37K | ﹤0.01% |
111
| – | – |
2015 Q2
1 quarter
|
|
|
GPIC
516
DELISTED
Gaming Partners International Corporation
GPIC
| $35K | ﹤0.01% |
1,128,275
+16,500
| +1% | +$166K |
2013 Q2
9 quarters
|
|
517
Theriva Biologics
TOVX
$9.54M
| $31K | ﹤0.01% |
+2
| New | +$49.2K |
2015 Q3
0 quarters
|
|
|
EXXI
518
DELISTED
ENERGY XXI LTD COM SHS
EXXI
| $27K | ﹤0.01% |
25,566
+10,320
| +68% | +$17.3K |
2014 Q4
3 quarters
|
|
519
Fortuna Silver Mines
FSM
$3.17B
| $22K | ﹤0.01% |
10,000
| – | – |
2013 Q2
9 quarters
|
|
520
FuelCell Energy
FCEL
$1.04B
| $20K | ﹤0.01% |
+6
| New | +$21.8K |
2015 Q3
0 quarters
|
|
|
ARNA
521
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $19K | ﹤0.01% |
+1,000
| New | +$34K |
2015 Q3
0 quarters
|
|
522
DELISTED
BLUE EARTH, INC. COMMON STOCK
BBLU
| $19K | ﹤0.01% |
27,900
| – | – |
2014 Q3
4 quarters
|
|
523
B2Gold
BTG
$7.01B
| $11K | ﹤0.01% |
+10,000
| New | +$12.2K |
2015 Q3
0 quarters
|
|
524
Denison Mines
DNN
$2.06B
| $10K | ﹤0.01% |
25,000
| – | – |
2013 Q2
9 quarters
|
|
525
DELISTED
BKF CAPITAL GROUP,INC
BKF
| $9K | ﹤0.01% |
17,000
| – | – |
2013 Q2
9 quarters
|
|
Similar funds
CAM
DL
TCM
HCM
AL
AT
Geneva Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, Geneva Advisors held 765 positions worth $4.96B, down 11% from $5.6B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geneva Advisors withdrew a net $193M in Q3 2015, closing 98 positions and reducing 270 holdings. Its most notable exit was Potash Corp Of Saskatchewan, an estimated $21.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Geneva Advisors opened a new position in Alphabet (Google) Class A worth $15.8M.
- Geneva Advisors's largest Q3 2015 buy was Alphabet (Google) Class A: 496,420 shares worth $15.8M.
- Geneva Advisors added most to Manhattan Associates in Q3 2015, an estimated $33.6M increase.
- Geneva Advisors's biggest Q3 2015 reduction was Biogen, cutting an estimated $49.9M.
- Geneva Advisors fully exited Potash Corp Of Saskatchewan in Q3 2015, selling an estimated $21.6M.
- Geneva Advisors's ten largest holdings make up 23% of its $4.96B portfolio in Q3 2015.
- Geneva Advisors opened 46 new positions and closed 98 in Q3 2015.
- Geneva Advisors's portfolio value fell 11% quarter-over-quarter to $4.96B.
Based on Geneva Advisors's 13F filing for Q3 2015, filed 3 Nov 2015.